» Articles » PMID: 1728251

Chromosome Fragility and Psychopathology in Obligate Female Carriers of the Fragile X Chromosome

Overview
Specialty Psychiatry
Date 1992 Jan 1
PMID 1728251
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The relationship between fragility (the percentage of cells exhibiting the fragile X chromosome abnormality) and psychopathological conditions was investigated in a sample of 40 obligate female carriers of the fragile X chromosome. Subjects were categorized by those with positive fragility greater than 0% (n = 19) and those with 0% fragility (n = 21). Compared with women with 0% fragility, it was expected that women with positive fragility would have a higher likelihood of manifesting a spectrum of social and psychological disability previously shown to be associated with fragile X syndrome in women. It was also expected that within the group with positive fragility, degree of fragility would be related to severity of symptoms. Results partially supported the hypotheses: women with fragility over 0% were more likely to be assigned a diagnosis of schizotypal features, were rated higher on symptoms associated with the schizophrenia spectrum, and scored lower on IQ, level of healthiest functioning, education, and socioeconomic status than women with 0% fragility. Subsequent comparisons with a control group indicated that the group with 0% fragility and normal controls did not differ on these variables. Within the group with positive fragility, increasing fragility was related to greater severity of symptoms and lower IQ, education, socioeconomic status, and levels of adaptive functioning, as predicted. Contrary to expectations, positive fragility was not associated with proportion of affective disorder diagnoses or ratings on affective disorder symptoms. The results of the study provide evidence that degree of fragility is a potentially important predictor of psychopathology among women with normal IQ who are carriers of the fragile X chromosome abnormality.

Citing Articles

Fragile X-associated disorders: a clinical overview.

Gallagher A, Hallahan B J Neurol. 2011; 259(3):401-13.

PMID: 21748281 DOI: 10.1007/s00415-011-6161-3.


Developmental malformation of the corpus callosum: a review of typical callosal development and examples of developmental disorders with callosal involvement.

Paul L J Neurodev Disord. 2011; 3(1):3-27.

PMID: 21484594 PMC: 3163989. DOI: 10.1007/s11689-010-9059-y.


Neural phenotypes of common and rare genetic variants.

Bearden C, Glahn D, Lee A, Chiang M, van Erp T, Cannon T Biol Psychol. 2008; 79(1):43-57.

PMID: 18395317 PMC: 2535822. DOI: 10.1016/j.biopsycho.2008.02.005.


Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders.

McConkie-Rosell A, Abrams L, Finucane B, Cronister A, Gane L, Coffey S J Genet Couns. 2007; 16(5):593-606.

PMID: 17497108 DOI: 10.1007/s10897-007-9099-y.


Social functioning among girls with fragile X or Turner syndrome and their sisters.

Mazzocco M, Baumgardner T, Freund L, Reiss A J Autism Dev Disord. 1999; 28(6):509-17.

PMID: 9932237 DOI: 10.1023/a:1026000111467.